A Luminenz-AT(pancrease) treatment study in children with autism
Project Description:
Investigators at the University of Texas Health Science Center at Houston are conducting a 180-week clinical study to assess the long-term safety and effectiveness of an investigational medication (CM-AT/LUMINENZ- AT) designed to treat behavioral and gastrointestinal symptoms of autism in children.
LUMINENZ- AT is an enzyme formulation children take with food to help them digest proteins. When protein is digested, it creates substances necessary for proper brain development and function.
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Education & Early Intervention, Child Care-Related Activities
Target Audience:
Professionals and Para-Professionals, Family Members/Caregivers, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
None
Primary Target Audience Geographic Descriptor:
Single-County
COVID-19 Related Data:
N/A